A Study of LY3041658 in Participants With Skin Diseases

Summary

The main purpose of this study is to investigate the safety and tolerability of the study drug known as LY3041658 in participants with certain types of skin diseases. The study will measure how the body absorbs, breaks down and gets rid of LY3041658. It will last about 127 days for each participant, not including screening. This study is for research purposes only, and is not intended to treat any medical condition.

Timeline

Start

2016-11-08

Primary completion

2019-03-19

Completion

2019-03-19

Drugs

Indications